Intas Pharmaceuticals Ltd — Exemestane Exporter Profile
Indian Pharmaceutical Exporter · #9 for Exemestane · $355.9K export value · DGFT Verified
Intas Pharmaceuticals Ltd is the #9 Indian exporter of Exemestane with $355.9K in export value and 13 verified shipments. Intas Pharmaceuticals Ltd holds a 2.5% market share in Exemestane exports across 4 countries.
Intas Pharmaceuticals Ltd — Exemestane Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Ltd Export Exemestane?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $1.7M | 78 | 39.5% |
| GERMANY | $740.7K | 25 | 17.6% |
| HUNGARY | $322.6K | 8 | 7.7% |
| UNITED KINGDOM | $282.0K | 15 | 6.7% |
| GREECE | $242.9K | 9 | 5.8% |
| AUSTRALIA | $175.8K | 5 | 4.2% |
| MALAYSIA | $139.9K | 9 | 3.3% |
| AUSTRIA | $109.2K | 19 | 2.6% |
| POLAND | $101.2K | 9 | 2.4% |
| SINGAPORE | $66.8K | 2 | 1.6% |
Intas Pharmaceuticals Ltd exports Exemestane to 21 countries. The largest destination is NETHERLANDS accounting for 39.5% of Intas Pharmaceuticals Ltd's Exemestane shipments, followed by GERMANY (17.6%) and HUNGARY (7.7%). These destinations reflect Intas Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Exemestane from Intas Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | UNITED KINGDOM | $681.4K | 51 |
| BROCACEF NL HUB | NETHERLANDS | $670.4K | 20 |
| FIEGE HEALTHCARE LOGISTICS GMBH | GERMANY | $558.2K | 19 |
| EUROPEAN PHARMAHUB | HUNGARY | $272.6K | 7 |
| ACCORD UK | UNITED KINGDOM | $217.7K | 7 |
| BROCACEF NL : HUB | NETHERLANDS | $202.5K | 12 |
| ACCORD HEALTHCARE SINGLE MEMBER SA | GREECE | $194.9K | 7 |
| PHARMA LOGISTIK AUSTRIA GMBH | ITALY | $162.9K | 24 |
| BROCACEF NL:HUB | NETHERLANDS | $137.4K | 5 |
| BROCACEF NL : DUTCH | NETHERLANDS | $94.2K | 4 |
Intas Pharmaceuticals Ltd supplies Exemestane to 40 buyers globally. The largest buyer is TO THE ORDER (UNITED KINGDOM), followed by BROCACEF NL HUB (NETHERLANDS) and FIEGE HEALTHCARE LOGISTICS GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Exemestane Export Value and How Much Does Intas Pharmaceuticals Ltd Contribute?
India exported $10.9M worth of Exemestane through 1,533 shipments from 87 suppliers to 57 countries, serving 196 buyers globally. Intas Pharmaceuticals Ltd contributes $355.9K to this total, accounting for 2.5% of India's Exemestane exports. Intas Pharmaceuticals Ltd ships Exemestane to 21 countries through 40 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Ltd's Exemestane Exports?
Intas Pharmaceuticals Ltd's average Exemestane shipment value is $27.4K per consignment, based on 13 shipments totaling $355.9K. The largest destination is NETHERLANDS (39.5% of Intas Pharmaceuticals Ltd's Exemestane exports).
How Does Intas Pharmaceuticals Ltd Compare to Other Indian Exemestane Exporters?
Intas Pharmaceuticals Ltd ranks #9 among 87 Indian Exemestane exporters with a 2.5% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($4.5M), MSN LABORATORIES PRIVATE LIMITED ($1.7M), EUGIA PHARMA SPECIALITIES LIMITED ($1.4M). Intas Pharmaceuticals Ltd processed 13 shipments to 4 destination countries.
What Exemestane Formulations Does Intas Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS & MEDI EXEMESTANE 25MG 10X1 | $396.1K | 13 |
| PHARMA DRUG&MED:EXEMESTANE 25MG 10X10T G | $351.8K | 8 |
| PHARMA DRUG&MED:EXEMESTANE 25MG 3X10T G1 | $192.6K | 11 |
| PHR DRUGS & MEDI EXEMESTANE 25MG 10T G1(ACCORD-EUROPE EACH FILM COATED TABLETSCONTAINS EXEMESTANE 25MG | $131.9K | 3 |
| PHARMA DRUGS & MEDI EXEMESTANE 25MG 3X10 | $123.2K | 8 |
| PHARMA DRUGS & MEDI EXEMESTANE TAB 25MG 3X10T G1ACCORD-UK AS PER DOCUMENT | $119.3K | 3 |
| PH.DRU. & MED.: EXEMESTAN SANDOZ 25MG TABLETS (EXEMESTANE TABLETS 25MG EACH TABLET CONT: EXEMESTANE 25MG) [3885X6X15T] PNOS | $116.6K | 3 |
| PHARMA DRUG&MED: EXEMESTANE 25MG EACH TABLET CONTAINS: EXEMESTANE...25MGNOS | $106.1K | 3 |
| PHARMA DRUGS MEDI EXEMESTANE 25MG 10X10T G1 ACCORD GERMANY AS PER INVOICE | $100.0K | 2 |
| PHARMA DRUGS & MEDI EXEMESTANE TAB 25MG 3X10T G1(ACCORD-UK AS PER INVOICE | $98.4K | 4 |
Intas Pharmaceuticals Ltd exports 125 distinct Exemestane formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI EXEMESTANE 25MG 10X1 with 13 shipments worth $396.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Exemestane to Key Markets
What Intas Pharmaceuticals Ltd must comply with to export Exemestane to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Ltd Compare to Nearest Exemestane Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | CIPLA LIMITED | $800.0K | 16 | 3 | $50.0K |
| 6 | TITAN LABORATORIES PRIVATE LIMITED | $500.0K | 10 | 1 | $50.0K |
| 9 | INTAS PHARMACEUTICALS LTD ★ | $355.9K | 13 | 4 | $27.4K |
| 7 | ZYDUS LIFESCIENCES LIMITED | $300.0K | 6 | 1 | $50.0K |
| 8 | CADILA HEALTHCARE LIMITED | $200.0K | 4 | 1 | $50.0K |
Intas Pharmaceuticals Ltd ranks #9 among 87 Indian Exemestane exporters. Average shipment value of $27.4K compared to the market average of $124.9K. The closest competitors by value are CIPLA LIMITED and TITAN LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Exemestane Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 314 | 20.5% |
| DELHI AIR CARGO ACC (INDEL4) | 273 | 17.8% |
| SAHAR AIR | 256 | 16.7% |
| DELHI AIR | 128 | 8.3% |
| Bombay Air Cargo | 62 | 4.0% |
| MUNDRA SEA (INMUN1) | 52 | 3.4% |
| MUNDRA SEA | 51 | 3.3% |
| AHEMDABAD AIR ACC (INAMD4) | 50 | 3.3% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Exemestane — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Exemestane shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 273 individual customs records matching Intas Pharmaceuticals Ltd exporting Exemestane, covering 125 formulations to 21 countries via 40 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 57+ countries, 196+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Exemestane Export Data from Intas Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Ltd's Exemestane exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Exemestane Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Exemestane. For current shipment-level data, contact TransData Nexus.